AbbVie: Argus Research raises target price to $320
ABBV•Argus Research raised its target price for AbbVie to $320.
Related News
Bragg Gaming names Morten Tonnesen interim CEO
BRAG•
Cameco Corporation: Stifel cuts target price to C$175 from C$180
CCJ•
Alphabet takes $548 million stake in partner Qualcomm in data center push
QCOM•
Plains GP Holdings Q3 swings to diluted loss of $0.16 per Class A share
PAGP•
Strategic Education: Truist cuts target price to $60 from $90
STRA•